Early detection of cancer;Früherkennung: Definitionen und Anforderungen für die Gratwanderung zwischen Nutzen und Schaden

Onkologe

Volumn 8, Issue 10, 2002, Pages 1030-1039

  Holzel D ^a   Engel, J ^a   Kunath, H ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER SCREENING; CANCER SURVIVAL; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; HUMAN; METASTASIS; PROSTATE CANCER; REVIEW; UTERINE CERVIX CANCER;

EID: 0036823135     PISSN: 09478965     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00761-002-0400-2     Document Type: Review

References (26)

1. Altenhofen L, Brenner G (2001) Krankheitsfrüherkennung Krebs - Männer und Frauen. Teilnahmeschätzung für das Jahr 2000. ZI der Kassenärztlichen Versorgung
2. Barton MB, Harris R, Fletcher SW (1999) Does This Patient Have Breast Cancer? The Screening Clinical Breast Examination: Should It Be Done? How? JAMA 282: 1270-1280
3. Boone JM, Lindfors KK, Seibert JA (2002) Determining sensitivity of mammography from screening data, cancer incidence, and receiver-operating characteristic curve parameters. Med Decis Making 22: 228-237
4. Collins MM, Barry MJ (1996) Controversies in prostate cancer screening. Analogies to the early lung cancer screening debate. Jama 276: 1976-1979
5. Cunningham G (2002) The science and politics of screening newborns. N Engl J Med 346: 1084-1085
6. Elmore JG, Barton MB, Moceri VM et al. (1998) Ten-year risk of false positive screening mammograms and clinical breast examinations. New Engl J Med 338: 1089-1096
7. Elovainio L, Nieminen P, Miller AB (1997) Impact of cancer screening on women's health. Int J Gynaecol Obstet 58: 137-147
8. Feinstein AR (2002) Misguided efforts and future challenges for research on "diagnostic tests". J Epidemiol Community Health 56: 330-332
9. Flobbe K, Nelemans P J, Kessels AG et al. (2002) The role of ultrasonography as an adjunct to mammography in the detection of breast cancer, a systematic review. Eur J Cancer 38: 1044-1050
10. Gøtzsche PC, Olsen O (2000) Is screening for breast cancer with mammography justifiable? Lancet 355: 129-134
11. Hankey BF, Feuer EJ, Clegg LX et al. (1999) Cancer surveillance series: interpreting trends in prostate cancer-part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. J Natl Cancer Inst 91: 1017-1024
12. Kan L, Olivotto IA, Warren Burhenne LJ et al. (2000) Standardized abnormal interpretation and cancer detection ratios to assess reading volume and reader performance in a breast screening program. Radiology 215: 563-567
13. Kerlikowske K, Grady D, Rubin SM et al. (1995) Efficacy of screening mammography. A metaanalysis. J Am Med Assoc 273:149-154
14. Knottnerus JA, van Weel C, Muris JW (2002) Evaluation of diagnostic procedures. BMJ 324: 477-480
15. Lindfors KK, Rosenquist CJ (1995) The costeffectiveness of mammographic screening strategies. Jama 274: 881-884
16. Olsen O, Gøtzsche PC (2001) Screening for breast cancer with mammography (Cochrane Review). Cochrane Database Syst Rev 4: CD001877
17. rd en. European Comission
18. Sackett D, Haynes R, Tugwell P (1985) Clinical Epidemiology - A basic science for clinical medicine. Little, Brown and Company, Boston
19. Schilling FH, Spix C, Berthold F et al. (2002) Neuroblastoma screening at one year of age. N Engl J Med 346: 1047-1053
20. Shen Y, Zelen M (2001) Screening sensitivity and sojourn time from breast cancer early detection clinical trials: mammograms and physical examinations. J Clin Oncol 19: 3490-3499
21. Silverstein MJ (1997) Ductal carcinoma in situ of the breast. Br J Surg 84: 145-146
22. Slamon DJ, Leyland-Jones B, Shak S et al. (2001) Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 2001 344: 783-792
23. Sox H, Blatt M, Higgins M et al. (1988) Medical Decision Making, 1st edn. Butterworth-Heinemann
24. Statistisches Bundesamt (1998) Fachserie 12 (Gesundheitswesen), Reihe 4: Todesursachenstatistik in Dtl. Metzler Poeschel, Stuttgart
25. Wilson JM, Jungner YG (1968) Principles and practice of mass screening for disease. Bol Oficina Sanit Panam 65: 281-393
26. Woolf SH. (1995) Screening for prostate cancer with prostate-specific antigen. An examination of the evidence. N Engl J Med 333: 1401-1405